Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Alphagan 0.2% eye drops
1106000AABBAAAA
|
Alphagan | Brimonidine tartrate | Eye | 5,728 |
|
Ilube 5% eye drops
1108010C0BBAAAD
|
Ilube | Acetylcysteine | Eye | 5,382 |
|
Timolol 5mg/ml eye drops preservative free
1106000Z0AAAUAU
|
Timolol (Eye) | Timolol | Eye | 4,844 |
|
Sodium cromoglicate 2% eye drops preservative free
1104020T0AAAIAI
|
Sodium cromoglicate (Eye) | Sodium cromoglicate | Eye | 4,680 |
|
Timolol 0.25% eye gel
1106000Z0AAAPAP
|
Timolol (Eye) | Timolol | Eye | 4,624 |
|
Iopidine 5mg/ml eye drops
1108020J0BBABAB
|
Iopidine | Apraclonidine | Eye | 4,500 |
|
Softacort 3.35mg/ml eye drops 0.4ml unit dose
1103010ALBBAAAA
|
Softacort | Hydrocort sodiumphos | Eye | 4,421 |
|
Acetylcysteine 5% eye drops
1108010C0AAADAD
|
Acetylcysteine (Eye) | Acetylcysteine | Eye | 4,411 |
|
Dexamethasone 0.1% eye dps 0.5ml unit dose preservative free
1104010I0AAALAL
|
Dexamethasone (Eye) | Dexamethasone | Eye | 4,254 |
|
Cosopt iMulti 20mg/ml / 5mg/ml eye drops preservative free
1106000ABBBACAC
|
Cosopt | Dorzolamide and timolol | Eye | 4,232 |
|
Chloramphenicol 0.5% eye drops preservative free
1103010C0AAAJAJ
|
Chloramphenicol (Eye) | Chloramphenicol | Eye | 4,170 |
|
Sodium cromoglicate 2% eye dps 0.3ml ud preservative free
1104020T0AAAJAJ
|
Sodium cromoglicate (Eye) | Sodium cromoglicate | Eye | 4,026 |
|
Simple eye ointment
1108010N0AAACAC
|
Paraffin (Eye) | Paraffin soft yellow | Eye | 4,022 |
|
Lodoxamide 0.1% eye drops
1104020M0AAAAAA
|
Lodoxamide trometamol | Lodoxamide trometamol | Eye | 3,867 |
|
Hypromellose 0.3% / Dextran '70' 0.1% eye drops
1108010F0AAA4A4
|
Hypromellose | Hypromellose | Eye | 3,758 |
|
Lotemax 0.5% eye drops
1104010W0BBAAAA
|
Lotemax | Loteprednol etabonate | Eye | 3,735 |
|
Cyclopentolate 1% eye drops
1105000E0AAACAC
|
Cyclopentolate hydrochloride | Cyclopentolate hydrochloride | Eye | 3,648 |
|
Latanoprost 50micrograms/ml eye drops preservative free
1106000L0AAACAC
|
Latanoprost | Latanoprost | Eye | 3,637 |
|
Ofloxacin 0.3% eye drops
1103010Y0AAAAAA
|
Ofloxacin (Eye) | Ofloxacin | Eye | 3,626 |
|
Ketotifen 250micrograms/ml eye dps 0.4ml ud preserv free
1104020Y0AAABAB
|
Ketotifen Fumarate (Eye) | Ketotifen fumarate | Eye | 3,518 |
|
Loteprednol 0.5% eye drops
1104010W0AAAAAA
|
Loteprednol etabonate | Loteprednol etabonate | Eye | 3,460 |
|
Lacri-lube eye ointment
1108010L0BBAAAB
|
Lacri-lube | Liquid paraffin | Eye | 3,387 |
|
Ketotifen 250micrograms/ml eye drops
1104020Y0AAAAAA
|
Ketotifen Fumarate (Eye) | Ketotifen fumarate | Eye | 3,153 |
|
Minims prednisolone sodium phosphate 0.5% eye dps 0.5ml ud
1104010S0BBAAAP
|
Minims prednisolone sodium phosphate | Prednisolone sodium phosphate | Eye | 2,981 |
|
Tobradex 3mg/ml / 1mg/ml eye drops
1104010I0BFAAAP
|
Tobradex | Dexamethasone | Eye | 2,950 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.